Cargando…
From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?
Imidazothiazole derivatives are becoming increasingly important in therapeutic use due to their outstanding physiological activities. Recently, applying imidazothiazole as the core, researchers have synthesized a series of derivatives with biological effects such as antitumor, anti-infection, anti-i...
Autores principales: | Guo, Mu, Yu, Xiangbin, Zhu, Yi Zhun, Yu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343371/ https://www.ncbi.nlm.nih.gov/pubmed/37446714 http://dx.doi.org/10.3390/molecules28135052 |
Ejemplares similares
-
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
What do we know about IL-6 in COVID-19 so far?
por: Jiang, Jingrui, et al.
Publicado: (2021) -
What we know so far
Publicado: (2021) -
Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021) -
Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)